Extra Follow-Up Confirms Benefit of Nivolumab in Muscle-Invasive Bladder Cancer

Press/Media

Period	Jun 8 2023

Media coverage

Title	Extra Follow-Up Confirms Benefit of Nivolumab in Muscle-Invasive Bladder Cancer
Media name/outlet	MedPage Today
Country/Territory	United States
Date	06/8/23
URL	https://www.medpagetoday.com/meetingcoverage/auaexpertvideoroundtable/104903
Persons	Alexander Kutikov